North America Nucleotide Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$331.8

Forecast, 2030 (US$M)

$526.5

CAGR, 2024 - 2030

6.8%

Report Coverage

North America

North America nucleotide market, 2018-2030 (US$M)

Related Markets

Global Nucleotide Industry Outlook

Europe Nucleotide Market Outlook

Asia Pacific Nucleotide Market Outlook

Latin America Nucleotide Market Outlook

MEA Nucleotide Market Outlook

North America nucleotide market highlights

The North America nucleotide market generated a revenue of USD 331.8 million in 2023.
The market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
In terms of segment, deoxy nucleotides was the largest revenue generating product in 2023.
Deoxy Nucleotides is the most lucrative product segment registering the fastest growth during the forecast period.

North America data book summary

Market revenue in 2023	USD 331.8 million
Market revenue in 2030	USD 526.5 million
Growth rate	6.8% (CAGR from 2023 to 2030)
Largest segment	Deoxy nucleotides
Fastest growing segment	Deoxy Nucleotides
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Deoxy Nucleotides
Key market players worldwide	Thermo Fisher Scientific Inc, Roche, Biorigin, DSM, Promega, Agilent Technologies Inc, ABF Ingredients

Other key industry trends

In terms of revenue, North America region accounted for 39.0% of the global nucleotide market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 328.8 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Nucleotide Market Scope

Nucleotide market segmentation & scope

Product

Deoxy Nucleotides

Dideoxynucleotides

Nucleotides for RNA Synthesis (rNTP)

Labelled Nucleotides

Application

Pharmaceuticals

Diagnostics research

Food & beverage additive

Animal feed additive

Others

Technology

TaqMan allelic discrimination

Gene chips & microarrays

SNP by pyrosequencing

Others

Regions

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Countries

U.S.

Canada

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Japan

China

India

Australia

South Korea

Thailand

Mexico

Brazil

South Africa

Saudi Arabia

Argentina

UAE

Kuwait

Nucleotide Market Companies

Name	Profile	# Employees	HQ	Website

North America nucleotide market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleotide market will help companies and investors design strategic landscapes.

Deoxy nucleotides was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America nucleotide market based on deoxy nucleotides covering the revenue growth of each sub-segment from 2018 to 2030.

North America was the second largest market for nucleotides, accounting 30.4% of the global share by revenue in 2018. North America was one of the major regions in the globe for SNP by pyrosequencing owning to the early origin of SNP technology in the region coupled with rising awareness and demand pertaining to increasing diagnostic research, animal breeding and pharmacogenomics sector.

The rising self-medication trends and cancer concerning research is expected to propel market demand. U.S. is the leading market as the pharmaceutical’s companies in the country account for over 35% of the global share. Nucleotides are used in the infant formulations, beverages, dairy products and bakery products.

Furthermore, rising consumer awareness related to the ill effects of savory ingredients such as summer savory and yeast is expected to augment the demand for nucleotides-based flavor enhancers in the region.

Reasons to subscribe to North America nucleotide market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America nucleotide market databook

Our clientele includes a mix of nucleotide market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America nucleotide market , including forecasts for subscribers. This continent databook contains high-level insights into North America nucleotide market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list